Table 4

Tumor responses in patients treated with CPIs

Type of cancer Patients, n/N (%)
Cutaneous melanoma8/11 (73)
Ocular melanoma1/3 (33)
Non–small-cell lung cancer3/4 (75)
Renal cell carcinoma3/3 (100)
Other cancers*4/6 (67)
  • n/N, n with diabetes with partial or complete tumor response/total N of patients.

  • *Other cancers include gastrointestinal adenocarcinoma, cholangiocarcinoma, small-cell lung cancer, primitive neuroectodermal tumor (PNET), Lynch syndrome (hereditary nonpolyposis colorectal cancer), pancreatic cancer, squamous cell carcinoma (tongue).